RE-BVS – Piemonte Repository

Sfoglia per AUTORE
COMANDONE A
Collezione ASL Asti

Items : 6

Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2024 Mar 1;32(3):202. doi: 10.1007/s00520-024-08392-8.

2024
ASL Asti
AOU Alessandria
AO Ordine Mauriziano

Cinieri S; Rossetti G; Airoldi M; Rossi M; Lanzetta G; Cavanna L; Ibrahim T; Bossi P; Santini D; Tucci M; De Giorgi U; Valsecchi AA; Comandone A; Di Maio M; Fusco V;

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.

2024
ASL Cuneo 2
ASL Asti
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Tucci M; Gennari A; Maio MD; Buttigliero C; Ortega C; Rossi M; Vellani G; Airoldi M; Vormola R; Numico G; Depetris I; Comandone A; Buosi R; Stevani I; Guglielmini P; Icardi M; Dionisio R; Cattrini C; Vignani F; Brusa F; Prati V; Ruatta F; Filippi R; Mennitto A; Vana F; Fea E; Vanella P; Pisano C; Turco F; et alii...

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Sep;155:127-135. doi: 10.1016/j.ejca.2021.06.034. Epub 2021 Aug 6.

2021
ASL Asti
AO Cuneo
ASL Città di Torino
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Biella

Berruti A; Tucci M; Gennari A; Baier S; Bellissimo AR; Ciccone G; Montagnani F; Comandone A; Chiappino I; Dal Canton O; Masini C; Sacco C; Zamparini M; Sirotova Z; Fea E; Valcamonico F; Vanella P; Ortega C; Buttigliero C; Prati V; Bianchi S; Mosca A; Dalla Volta A; Amoroso D;

Antiangiogenic Therapy in Clear Cell Renal Carcinoma (CCRC): Pharmacological Basis and Clinical Results. in Cancers / Cancers (Basel). 2021 Nov 24;13(23):5896. doi: 10.3390/cancers13235896.

2021
ASL Asti
ASL Città di Torino

Tucci M; Comandone T; Vana F; Comandone A;

Maintenance versus discontinuation of androgen deprivation therapy during docetaxel administration with a continuous or an intermittent schedule in metastatic, castration resistant, prostate cancer patients. A multicenter randomized phase III study of the piemonte oncology network in Tumori

2020
ASL Torino 4
ASL Asti
ASL Biella
ASL Vercelli

Bianchi S; Alessandra M; Prati V; Ortega C; Buttigliero C; Fea E; Vanella P; Valcamonico F; Ciccone G; Sirotova Z; Chiappino I; Dal Canton O; Masini C; Saccot C; Amoroso D; Leone F; Comandone A; Gennari A; Berruti A; Tucci M;

Maintenance versus discontinuation of androgen deprivation therapy during docetaxel administration with a continuous or an intermittent schedule in metastatic, castration resistant, prostate cancer patients: A multicenter randomized phase III study of the Piemonte Oncology Network in Annals of Oncology

2020
ASL Asti
ASL Biella

Berruti A; Mosca A; Bianchi S; Prati V; Ortega C; Buttigliero C; Fea E; Vanella P; Valcamonico F; Ciccone G; Sirotova Z; Chiappino I; Canton OD; Masini C; Sacco† C; Amoroso D; Montagnani F; Comandone A; Gennari A; Tucci M;